Disclosure Of Cash Flow Statement [Text Block]

Sopharma Trading AD - Filing #6022483

Concept As at
2023-12-31
As at
2022-12-31
As at
2021-12-31
Disclosure of cash flow statement [text block]
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
13 112 BGN
6 833 BGN
Cash and cash equivalents if different from statement of financial position
13 108 BGN
6 829 BGN
11 689 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.